Drimva

Novartis

AD, Data Partnerships - Rare Disease

$146K–$270K

Remote Position (USA) · Full-time · Posted Sep 1, 2026

Experience
Minimum 6 years; focused on rare disease, healthcare data, data governance, data management, or related roles.
Education
Bachelor’s or Master’s degree in Information Management, Computer Science, Business Administration, or related field.

About the job

Establishes and oversees rare disease data partnerships, guiding internal teams in selecting, governing, and using external data to support US Commercial business decisions.

What you'll do

  • Implement rare disease data partnership strategy and manage relationships with external data providers, platforms, and vendors.
  • Oversee data quality, privacy, security, compliance, governance, and stewardship across external partnerships.
  • Track partnership spend and performance, report metrics to leadership, and advise stakeholders on data sources and their appropriate use.

What they ask for

  • Bachelor’s or Master’s degree in Information Management, Computer Science, Business Administration, or a related field.
  • Minimum 6 years of experience establishing and managing data partnerships, with a strong focus on rare disease, healthcare data, data governance, data management, or related roles.
  • Deep understanding of rare disease data assets, partnership principles, and healthcare data privacy, security, quality, and compliance.
  • Strong leadership, communication, stakeholder management, influencing, change management, analytical, and problem-solving skills.

Nice to have

  • Prior experience working with or for a data vendor, data provider, healthcare data platform, or analytics organization.
  • Experience with IQVIA, Komodo, MMIT, Symphony, Definitive Healthcare, Veeva, claims/EHR data providers, patient services data, specialty pharmacy data, or similar sources.

Pay

$145,600.00 - $270,400.00 USD base salary

Tools

IQVIA, Komodo, MMIT, Symphony, Definitive Healthcare, Veeva, claims/EHR data

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)